Abstract
Several new clonidine analogs were synthesized and their ability to inhibit [3H] phentolamine binding to human platelet α2-adrenergic receptors was tested. The order of potency and calculated dissociation constants for clonidine and its analogs were as follows: clonidine (0.020 ± 0.005 μM) > p-aminoclonidine (0.100 ± 0.010 μM) > hydroxy-phenacetyl-aminoclonidine (0.20 ± 0.03 μM) > p-dansyl clonidine (1.00 ± 0.20 μM) > t-boc-tyrosine clonidine (1.80 ± 0.60 μM). Thus, p-amino substitution reduces α2-adrenergic affinity in the platelet system. The effects of clonidine and its p-amino analogs on platelet adenylate cyclase were also evaluated. This enzyme is inhibited by epinephrine acting via α2-adrenergic receptors. Both clonidine and p-aminoclonidine cause slight inhibition of basal adenylate cyclase and reverse the inhibition induced by epinephrine. These observations indicate that clonidine is a partial agonist for platelet α2-adrenergic receptors.
Original language | English |
---|---|
Pages (from-to) | 389-394 |
Number of pages | 6 |
Journal | Biochimica et Biophysica Acta - General Subjects |
Volume | 714 |
Issue number | 3 |
DOIs | |
State | Published - 25 Feb 1982 |
Keywords
- (Human platelet)
- Clonidine
- Receptor binding
- Yohimbine
- α-Adrenergic receptor